Implementation of new medicine pricing formula temporarily stalled: NMRA
09-Nov-2026.
The implementation of the new medicine pricing formula has resulted in price reductions of between 30 and 40 per cent for certain medicines. However, the National Medicines Regulatory Authority (NMRA) has said that legal action challenging the pricing formula has temporarily hindered plans to implement the scheme.
NMRA Chairman Dr. Ananda Wijewickrama said:
Despite the depreciation of the rupee against the US dollar, medicine prices have declined following the introduction of the new pricing formula. In particular, the prices of certain medicines have fallen significantly by around 30 to 40 per cent.
These reductions indicate that some medicines had previously been sold at excessively high prices. Measures to regulate medicine prices were introduced primarily to protect consumers.
However, following legal action instituted by the Pharmaceutical Importers Association challenging the relevant Gazette notification, efforts to extend the pricing formula to registered medicines have been temporarily stalled.
There are currently around 6,000 registered medicines in Sri Lanka. However, the authority does not intend to impose maximum retail prices on all products simultaneously. Instead, it plans to introduce price controls gradually through the medicine registration and import licensing processes.
He said the legal proceedings would have to be concluded before the scheme could be implemented and that the process could take between one-and-a-half and two years.





